Nhs_choices Bthft Bradford Teaching HospitalsNHS Foundation Trust NHS Choices
  • Text Size

  • Language

    loading

03 - Respiratory

NICE Technologies Applicable to this BNF Section
TA Number TA Subject Has the recommendation in the TA been implemented in the organisation for example by changes to the local formulary for drugs, procurement of devices or changes to care pathways? (Yes/No/TA Not Applicable to this organisation)
TA282 Idiopathic pulmonary fibrosis - pirfenidone (TA282) TA not applicable to this organisation (Pulmoary fibrosis patients are managed by Leeds Teaching Hospital NHs Foundation Trust). any patient who has commenced therapy in another trust will continue to be presribed the treatment locally 
TA278 Asthma (severe, persistent, patients aged 6+, adults) - Omalizumab (rev TA133, TA201)(TA278) Yes
TA266 Cystic fibrosis - mannitol dry powder for inhalation (TA266)  TA not applicable to this organisation (Cystic fibrosis patients are managed by Leeds Teaching Hospital NHS Foundation Trust). Any patient who has commenced therapy in another trust will continue to be prescribed the treatment locally
TA246
Venom anaphylaxis - immunotherapy (Pharmalgen) (TA246)
TA not applicable to this organisation (we are not a centre with specialists in venom immunotherapy)
TA244 Chronic obstructive pulmonary disease - roflumilast (TA244) TA not applicable to this organisation (there is no research currently in progress locally)
TA201
Asthma (in children) - Omalizumab (TA201)
Yes
TA139 Sleep apnoea - continuos positive airway pressure (CPAP) (TA139) Yes
TA138 Asthma (in adults) - corticosteroids (TA138) Yes
TA133
Asthma (uncontrolled) - Omalizumab (TA133)

Yes
TA131 Asthma (in children) - corticosteroids TA131 Yes
TA38 Asthma (older children) - Inhaler devices (TA38) Yes
TA10
Asthma (children under 5) - Inhaler devices (TA10)
Yes